New study reveals new drug target for gout & inflammatory diseases
Research reveals cathepsins as potential therapeutic targets in particulate-mediated inflammatory disease…
List view / Grid view
Research reveals cathepsins as potential therapeutic targets in particulate-mediated inflammatory disease…
A new portable device can quickly find markers of deadly, unpredictable sepsis infection from a single drop of blood.
A study led has found that the model for the spread of carcinoma - from the primary tumour, to nearby lymph nodes, to other organs - may not apply in all cases.
Researchers at the MRC Laboratory of Molecular Biology (LMB) have, for the first time, revealed the atomic structures of one of the two types of the abnormal filaments which lead to Alzheimer's disease.
Lung cancer screening is likely to be cost-effective, particularly if it also identifies other tobacco-related conditions in high-risk people, suggests new research.
Moving genes about could help cells to respond to change according to scientists at the Babraham Institute in Cambridge, UK and the Weizmann Institute, Israel.
Scientists have discovered a link between a major mechanism of antibiotic resistance and resistance to the common disinfectant triclosan...
Nemus Bioscience announced that THC derived from NB1111 achieved significant tissue concentrations in multiple compartments of the eye...
The DFG has agreed to fund the Mainz-based Collaborative Research Center involved in the development of nanomaterials for cancer immunotherapy...
A team of researchers has discovered the role of the protein ZBTB48 in regulating both telomeres and mitochondria, key players involved in cellular ageing.
Research from King’s College in London, UK, and Lund University in Sweden could explain why diabetes drugs that have worked in animal experiments are not equally successful in humans. The researchers discovered differences – as well as hitherto unknown similarities – in the function of insulin-producing beta cells.
This latest funding round attracts two prominent new investors; Brian Kennedy and Sir Brian Souter.
A method to more accurately test anti-cancer drugs has now been developed at the Sahlgrenska Academy, University of Gothenburg.
For nearly two decades researchers have sought a way to target an oestrogen receptor in the hope they could improve breast cancer survival, but an article contends that the effort may never pan out.
A new scorpion-milking robot designed to extract venom could replace the traditional manual method.